Reported Standalone quarterly numbers for Astec Lifesciences are:Net Sales at Rs 126.97 crore in March 2023 down 53.32% from Rs. 271.98 crore in March 2022.
Quarterly Net Loss at Rs. 5.00 crore in March 2023 down 111.61% from Rs. 43.04 crore in March 2022.
EBITDA stands at Rs. 7.96 crore in March 2023 down 88.99% from Rs. 72.27 crore in March 2022.
| Astec Life shares closed at 1,351.65 on May 02, 2023 (NSE) and has given -36.64% returns over the last 6 months and -30.71% over the last 12 months. |
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 126.97 | 117.18 | 271.98 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 126.97 | 117.18 | 271.98 | | EXPENDITURE | | Consumption of Raw Materials | 76.49 | 111.02 | 154.02 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 9.76 | -41.30 | 10.32 | | Power & Fuel | -- | -- | -- | | Employees Cost | 12.86 | 11.40 | 16.72 | | Depreciation | 7.77 | 8.81 | 10.66 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 22.47 | 23.94 | 25.46 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.37 | 3.32 | 54.81 | | Other Income | 2.57 | 3.78 | 6.80 | | P/L Before Int., Excpt. Items & Tax | 0.19 | 7.10 | 61.61 | | Interest | 6.41 | 5.88 | 3.33 | | P/L Before Exceptional Items & Tax | -6.21 | 1.21 | 58.28 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.21 | 1.21 | 58.28 | | Tax | -1.22 | 0.39 | 15.24 | | P/L After Tax from Ordinary Activities | -5.00 | 0.83 | 43.04 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.00 | 0.83 | 43.04 | | Equity Share Capital | 19.61 | 19.61 | 19.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.55 | 0.42 | 21.97 | | Diluted EPS | -2.55 | 0.42 | 21.97 | | EPS After Extra Ordinary | | Basic EPS | -2.55 | 0.42 | 21.97 | | Diluted EPS | -2.55 | 0.42 | 21.97 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|